Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
about
Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro.Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1Hypertrophic differentiation of mesenchymal stem cells is suppressed by xanthotoxin via the p38‑MAPK/HDAC4 pathway.Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
P2860
Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@en
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@nl
type
label
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@en
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@nl
prefLabel
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@en
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@nl
P2093
P2860
P1476
Xanthotoxin prevents bone loss ...... KL-induced osteoclastogenesis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-016-3496-8
P407
P577
2016-01-25T00:00:00Z